Study to Compare the Immunogenicity and Safety of 3 Lots of NVX-CoV2373 in Adults
Study sponsor: Novavax
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2022-08-17Actual
Enrollment · participants911Actual
Source updated2026-04-17Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.